180 Participants Needed

Low Vision Rehabilitation + Emotion Regulation Therapy for Visual Impairment

JS
Overseen ByJessica Stout
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether combining Low Vision Rehabilitation (LVR) with Emotion Regulation Therapy (ERT) can assist individuals with inherited retinal diseases (IRDs) who experience emotional distress from vision loss. The study aims to determine if LVR can enhance daily functioning and if adding ERT can further aid those with high vision-related anxiety. Participants will receive either LVR alone or a combination of LVR and ERT, based on their anxiety levels. Ideal candidates have an IRD diagnosis, have recently consulted a specialist, and experience anxiety due to vision loss. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve emotional well-being for those with vision loss.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are on medication for mental health, you must be on a stable dose for at least one month to participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Earlier studies have examined Emotion Regulation Therapy (ERT) for its ability to help people manage emotional distress. Research shows that ERT effectively improves emotional control and well-being, particularly for those with vision problems. Reports of negative effects from ERT are rare, indicating it is generally well-tolerated.

Low Vision Rehabilitation (LVR) helps individuals maximize their remaining sight. One study found that LVR improved vision abilities in many participants, with 71% experiencing significant benefits within a year. This suggests LVR is effective and safe, as no serious side effects have been reported.

Both ERT and LVR have demonstrated safety in various settings, with no major safety concerns noted in the studies.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments because they combine Low Vision Rehabilitation (LVR) with Emotion Regulation Therapy (ERT), offering a comprehensive approach to managing visual impairment and associated anxiety. Unlike traditional methods that focus solely on improving visual function, this trial addresses the emotional distress that often accompanies vision loss. ERT equips patients with strategies to manage anxiety, potentially enhancing the effectiveness of LVR by fostering a more positive mental state. This holistic approach is promising because it targets both the physical and emotional aspects of visual impairment, aiming to improve overall quality of life for patients.

What evidence suggests that this trial's treatments could be effective for visual impairment?

This trial will compare different approaches to managing vision-related challenges. Research has shown that combining Low Vision Rehabilitation (LVR) and Emotion Regulation Therapy (ERT) can help people with inherited retinal diseases (IRDs) manage emotional distress more effectively. In this trial, participants in Arm 1 will receive LVR alone, which studies indicate can improve vision-related skills and quality of life for nearly half of the patients. Arm 2 participants will receive ERT initially, followed by concurrent LVR, focusing on managing emotional challenges, which can be especially helpful for those experiencing anxiety due to vision problems. Arm 3 participants will receive LVR with delayed ERT. By addressing both vision and emotional issues, this combined approach aims to offer more complete support for individuals dealing with vision loss. Early evidence suggests that using both LVR and ERT together may lead to better results than using either one alone.12678

Who Is on the Research Team?

KT

K. Thiran Jayasundera, MD, MS

Principal Investigator

University of Michigan

Are You a Good Fit for This Trial?

This trial is for individuals with inherited retinal diseases who are experiencing emotional distress due to vision loss. Participants should be emotionally distressed specifically because of their visual impairment.

Inclusion Criteria

I can attend 10 weeks of sessions in Michigan.
Have had a Goldmann visual field that was tested with III-4e isopter within the last year
Have a disability greater than zero theta in any of the domains of Michigan Retinal Dystrophy Questionnaire (MRDQ)
See 3 more

Exclusion Criteria

I am currently receiving treatment for a mental health condition.
The participant must not have an elevated suicidal intention (SI) or suicide risk based on Patient Health Questionnaire (PHQ-9) further information collected at screening (If suicidal intentions are identified, the study staff will complete the suicide protocol (per protocol)
My mental health medication dose has been stable for at least a month.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Low Vision Rehabilitation (LVR) and Emotional Regulation Therapy (ERT) based on their randomization group

6 months
Regular sessions as per therapy protocol

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Emotion Regulation Therapy (ERT)
  • Low Vision Rehabilitation (LVR)
Trial Overview The study aims to determine if Low Vision Rehabilitation (LVR) combined with Emotion Regulation Therapy (ERT) can improve the well-being of patients with inherited retinal diseases and related emotional distress.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 3- LVR with delayed ERTExperimental Treatment2 Interventions
Group II: Arm 2 - ERT (after randomization) and then concurrent with LVRExperimental Treatment2 Interventions
Group III: Arm 1 - Low Vision Rehabilitation LVRActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

National Eye Institute (NEI)

Collaborator

Trials
572
Recruited
1,320,000+

Published Research Related to This Trial

Patients with acquired brain injury (ABI) take longer and generate fewer reappraisals for regulating emotions compared to healthy controls, indicating a potential challenge in emotion regulation after brain injury.
While ABI patients can effectively decrease the intensity of negative emotions, their ability to up-regulate neutral emotions to positive is less effective, suggesting specific deficits in emotion regulation strategies that could inform neuropsychological rehabilitation efforts.
Good things better? Reappraisal and discrete emotions in acquired brain injury.Rowlands, L., Coetzer, R., Turnbull, OH.[2021]
The Emo-regulator, a training system combining virtual reality and EEG-based neurofeedback, effectively improved emotion regulation in subjects over a two-week period, as evidenced by enhanced ability to down-regulate negative emotions.
Participants reported above-average usability of the Emo-regulator, indicating that it not only helps in emotional management but is also user-friendly, promoting the use of cognitive reappraisal techniques.
Emo-regulator: An emotion-regulation training system fusing virtual reality and EEG-based neurofeedback.Yu, M., Bai, Y., Li, Y.[2023]
In a study involving 150 adults with chronic illnesses, Mind-body and Art Therapies (MBATs) showed a slight improvement in emotional regulation skills, but the difference compared to the control group was not statistically significant.
No adverse effects were reported from the MBAT interventions, indicating they are safe for patients with chronic diseases, although the overall effectiveness in enhancing emotional regulation was only partially supported.
Mind-body and art therapies impact on emotional regulation in patients with chronic diseases: a pragmatic mixed-methods randomized controlled trial.Le Rhun, A., Caillet, P., Lebeaupin, M., et al.[2023]

Citations

Low Vision Rehabilitation + Emotion Regulation Therapy ...The purpose of this study is to understand if combining Low Vision Rehabilitation (LVR) with Emotional Regulation Therapy (ERT) can help people with ...
Optimizing Low Vision Rehabilitation in Emotionally ...The purpose of this study is to understand if combining Low Vision Rehabilitation (LVR) with Emotional Regulation Therapy (ERT) can help people with inherited ...
Determining optimal vision care for emotionally distressed ...We will quantify longitudinal change in vision-related and emotional difficulties, limitations, and impairment by intervening with LVR and ERT ...
Schema therapy in partially sighted individuals with a focus ...This study aimed to investigate the effectiveness of schema therapy in addressing social isolation and enhancing self-esteem among partially sighted ...
Emotion regulation in blind and visually impaired children ...Blind children and visually impaired children each have lower emotion regulation ability than sighted children. •. This visual impairment effect is significant ...
Low vision rehabilitation for better quality of life in visually ...We included randomised controlled trials (RCTs) investigating HRQOL, VRQOL and related outcomes of adults, with an irreversible visual impairment (World Health ...
Improving Emotional Dysregulation and Well-Being among ...Results revealed that prevalence of depressive symptoms were. 50% higher among visually impaired as compared to those having normal vision [11].
Emotion Regulation Therapy (ERT) I: Historical and ...This chapter reviews (1) self-regulatory and functional perspectives on distress; (2) how the emotion regulation therapy (ERT) model can help ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security